ALSO READNeuland Laboratories enters into joint development agreement with Phoenix Embassy Techno Zone Neuland Laboratories standalone net profit rises 28.36% in the March 2017 quarter Neuland Laboratories to hold board meeting Neuland Laboratories to hold EGM Neuland Laboratories Board to consider December quarter results
Till 31 December 2017Neuland Laboratories has been granted approval for extension of time for holding its Annual General Meeting for the financial year 2016-17, till 31 December 2017, by the Registrar of Companies, Telangana & Andhra Pradesh.
The extension has been sought by the Company as it is in the process of the obtaining requisite approvals for the Scheme of Amalgamation and Arrangement between Neuland Laboratories (Transferee Company) and Neuland Health Sciences(First Transferor Company) and Neuland Pharma Research (Second Transferor Company) and their respective Shareholders and Creditors ('Scheme'), filed with the Hon'ble National Company Law Tribunal and the timelines involved for the proposed merger.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)